Advertisement

Responsive Advertisement
Showing posts from August, 2021Show All
The Covid-19 pandemic severely disrupted the workflow in the healthcare industry
Rise in number of surgical procedures contributes to the market growth
Infectious disease segment is anticipated to show significant growth during the forecast period
Ethical issues and lack of safety toward gene editing restrain the growth to some extent.
The consumables segment is projected to register the highest CAGR of 6.0% during the forecast period
Increase in prevalence of chronic diseases, surge in geriatric populations